Biercee, Belgium

Jeremy Reniers

This inventor holds 1 USPTO granted patent. Top assignees: Facultés Universitaires Notre-Dame De La Paix, Université Libre De Bruxelles. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy Reniers. Retrieved from https://idiyas.com/inventor/jeremy-reniers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeremy Reniers

Introduction

Jeremy Reniers is a notable inventor based in Biercee, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Reniers holds a patent for "Beta carboline derivatives useful in the treatment of proliferative disorders." This invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) that are useful in treating proliferative disorders, including cancer. The patent also details the intermediates used in their preparation, the processes for preparing these compounds, and their various uses.

Career Highlights

Throughout his career, Jeremy Reniers has worked with esteemed institutions such as Facultés Universitaires Notre-Dame de la Paix and Université Libre Bruxelles. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to important research initiatives.

Collaborations

Reniers has collaborated with notable colleagues, including Raphael Frederick and Bernard Masereel. These partnerships have further enhanced his research and development efforts in medicinal chemistry.

Conclusion

Jeremy Reniers is a distinguished inventor whose work in developing beta-carboline derivatives showcases his commitment to advancing medical treatments. His contributions to the field are significant and reflect his dedication to innovation in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…